What’s new at the Rosalind & Morris Goodman Cancer Institute?

For 30 years, the CURE foundation has been powering research and the fight against breast cancer. May 12th, 2026, is National Denim Day, their annual fundraiser.

A new study led by Adda-Lee Graham-Paquin, PhD, and GCI Principal Investigator Luke McCaffrey, PhD identifies a new mechanism for tissue remodelling and how prostate epithelial cells respond to hormone deprivation.

This Earth Day, the GCI invites you to see sustainability as an extension of our mission: both curing cancer and caring for our planet are acts of protecting human life.

Today we highlight Laura Wu, a Rosalind and Morris Goodman Cancer Institute Alumni, and the inspiring work she went on to pursue.

The GCI hosted the Let’s Talk Cancer Symposium event on March 26, 2026 , co-led by Research Information Outreach Team (RIOT) Montreal and Let’s Talk Science – McGill, designed to open the doors of academic science to young people and demonstrate what cancer research actually looks like from the inside. The day brought together keynote addresses, a talk on animal models in research by MICAM, hands-on wet lab workshops, lab tours, and activities addressing cancer knowledge and science misinformation.

The Rosalind & Morris Goodman Cancer Institute (GCI) is pleased to announce the appointment of Peter Siegel, PhD, as Associate Director, effective immediately. In this role, Professor Siegel will help guide the GCI’s strategic direction and support its mission to advance innovative cancer research, foster interdisciplinary collaboration, and translate scientific discoveries into improved outcomes for patients.

In honour of Colorectal Cancer Awareness Month, the Rosalind & Morris Goodman Cancer Institute (GCI) is highlighting the work of trainees whose research is advancing our understanding of cancer and improving the future of patient care. Today, we feature Yilin Wang, a PhD candidate in Biochemistry in the laboratory of Professor José Teodoro, whose research explores an important biological link between inflammatory bowel disease (IBD) and colorectal cancer.

This year, we are proud to recognize four trainees from the Rosalind and Morris Goodman Cancer Institute (GCI) who have been awarded the prestigious Doctoral Research Award from the Cancer Research Society (CRS).

BRCA1-related breast and ovarian cancers are aggressive—and despite being infiltrated by immune cells, they remain resistant to immunotherapy. New research led by Dr. Hannah Garner aims to uncover why the immune system fails to attack these tumours and how it can be reprogrammed to fight back.